Phen-fen frenzy

Clive, Teagan
January 1997
Joe Weider's Muscle & Fitness;Jan97, Vol. 58 Issue 1, p100
Focuses on the phentermine-fenfluramine (phen-fen) drug combination for weight loss. Effectiveness of the combination; Side effects; Disagreement between physicians on the drug combination; Background information on the phen-fen saga; Drug's potential for abuse. INSETS: Who gets phen-fen--and why.;How to win at losing.;Phen-fen's side effects..


Related Articles

  • Nationwide Class Action Lawsuit--Phen/Fen and Primary Pulmonary Hypertension. Brous, Edie // Journal of Nursing Law;Spring2005, Vol. 10 Issue 1, p5 

    This article describes the origin of phen/fen combination use and its subsequent involvement in claims of primary pulmonary hypertension from a defense perspective. The national settlement criteria for inclusion in the subsequent class action suit is detailed, with descriptions of manipulative...

  • Pulmonary Hypertension Associated with Use of Phentermine. Woo-Dae Bang; Ji-Ye Kim; Hee-Tae Yu; Sung-Soo Cho; Ji-Yong Jang; Chang-Myung Oh; Boyoung Joung; Hyuk-Jae Chang // Yonsei Medical Journal;11/1/2010, Vol. 51 Issue 6, p971 

    Weight-control drugs (known as anorexigens) such as fenfluramine have been linked with pulmonary hypertension in previous reports. In our case, a 29 year old woman was admitted for shortness of breath and was diagnosed with pulmonary hypertension. Three months ago, she had been taking...

  • Fen-phen: Risky for dieters in any form.  // Consumer Reports;Sep97, Vol. 62 Issue 9, p6 

    Reports on the dangers of the diet drug fen-phen and its herbal counterpart, Herbal Fen-Phen. Where Herbal Fen-Phen is sold; Why the US Food and Drug Administration recommended against the use of fen-phen; Deaths related to the use of fen-phen.

  • Every New Mexico drugstore sued over phen-fen. Conlan, Michael F. // Drug Topics;12/7/98, Vol. 142 Issue 23, p24 

    Reports on the state lawsuit against 281 community pharmacies in New Mexico filed at the District Court in Santa Fe in 1998. Allegations of the plaintiffs regarding the manufacturers and sellers of fenfluramine-phentermine; Highlights of the case.

  • Initial weight loss as a predictor of response to obesity drugs. Dhurandhar, N V; Blank, R C; Schumacher, D; Atkinson, R L // International Journal of Obesity & Related Metabolic Disorders;Dec1999, Vol. 23 Issue 12, p1333 

    BACKGROUND: Initial weight loss has been used as a predictor of long-term response to obesity drugs. Discontinuation of drugs has been recommended if weight loss is not ≥ 1.81 kg (4 Ib) in the first month of treatment. OBJECTIVE: We compared the weight loss response at 6 months of patients...

  • Tracking the `fenphen' drug trend.  // Physician & Sportsmedicine;Sep96, Vol. 24 Issue 9, p17 

    Reports on the popularity of the drugs fenfluramine and phentermine for weight reduction and appetite suppression. Mechanism by which both drugs promote weight loss; Prescription dosages of both drugs; Method by which physicians arrive at a decision to five the fenfluramine-phentermine...

  • Demise of fen-phen a weighty issue for S.D. dieters. Acello, Richard // San Diego Business Journal;11/10/97, Vol. 18 Issue 45, p13 

    Reports that dieters who have taken `fen-phen,' a two-pill combination of fenfluramine and phentermine, were found to have leaky heart valves. Information on Weight Watchers' `1-2-3 Success' weight loss program; Goal of the program; Other weight loss programs; Key to successful weight loss.

  • New research aims to assess Redux/phen-fen controversy. Shaw, Kendall // Drug Store News;12/14/98, Vol. 20 Issue 20, pCP23 

    Reports on the results of a study on the physiological effects of Redux or phentermine-fenfluramine intake. Average duration of Redux therapy; Rates of mild or greater aortic regurgitation; Mitral valve regurgitation; Cardiovascular symptoms; Aortic regurgitation.

  • Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status. Whigham, L. D.; Dhurandhar, N. V.; Rahko, P. S.; Atkinson, R. L. // International Journal of Obesity;May2007, Vol. 31 Issue 5, p850 

    Background:Obesity treatment with single drugs produces weight losses of about 8–10% of initial body weight. Few studies of combinations of drugs for treating obesity have been published. The combination of phentermine, an adrenergic agent, and fenfluramine, a serotonergic agent,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics